First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...

Tezepelumab demonstrated rapid and sustained clinical improvements in nasal polyp burden and symptom control, with effects ...

Denmark's economic growth, which was driven by what economists described as an "exceptional surge" in pharmaceutical exports, ...

The Chicago-based Tempus spinout called the financing round a major milestone as it expands its AI-enabled platform.

Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.

CEO Önal said Türk Telekom had a ‘spectacular’ start to the year, primarily driven by the maintained strength in fixed ...

Asthma biologics can be continued and initiated during conception, throughout pregnancy and while breastfeeding, especially ...

Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised ...

During a live event, Xiuning Le, MD, PhD, discussed clinical trials of supportive care for infusion reaction and skin rash ...

Treatment of optic neuritis with corticosteroids, findings from the Optic Neuritis Treatment Trial and the validity of ...

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress”), an innovative biopharmaceutical company focused on acquiring and ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...